AZD-6234

N/A

Report date: 2026/04/24 20:01:59
NME

Base Information

Drug NameAZD-6234
Drug Alias NameAZD-6234
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAmylin receptor agonists
TargetsAmylin Receptor
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca PlcAstrazeneca AbAstraZeneca global R & D (China) Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A